Zhendong Pharmaceutical (300158.SZ) released its third quarter report of 2023 on October 22nd. During the reporting period, operating income was 851 million yuan, down 20.74% from the same period last year. Net profit belonging to shareholders of listed companies was-15.4166 million yuan. Net profit belonging to shareholders of listed companies after deducting non-recurrent gains and losses was-20.3754 million yuan. Basic earnings per share was-0.0150 yuan per share.
振东制药(300158.SZ)：第三季度净亏损1541.66万元
Zhendong Pharmaceutical (300158.SZ): Net loss of 154.16,600 yuan in the third quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.